MacroGenics(MGNX) - 2022 Q4 - Annual Report

For the transition period from to Commission File Number 001-36112 OR UNITED STATES SECURITIES AND EXCHANGE COMMISSION ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 (Exact name of registrant) MACROGENICS, INC. Indicate by check mark if the registrant is a well-known seasoned issuer, as defin ...